SUMMARY
INTRODUCTION
Ascites is an important landmark and a poor prognostic factor in the clinical course of cirrhosis, while is also associated with an increased risk of spontaneous bacterial peritonitis (SBP) [1] and consequent development of acute decompensation that accounts for further risk of mortality in cirrhosis patients [2] . Early diagnosis and prompt management of SBP is therefore of critical im-portance in the management of cirrhotic ascites to prevent life-threatening complications such as hepatic encephalopathy and hepatorenal syndrome [3, 4] . In recent years, a change in epidemiology of bacterial infections has been documented in cirrhosis patients with an increase in the prevalence of SBP caused by multi-resistant bacteria associated with higher mortality rates than infections caused by pathogens that are sensitive to antimicrobials [5, 6] . Given the consideration of antibiotic resistance to be an independent life-threatening poor prognostic factor in cirrhotic patients with SBP, prompt identification of antibiotic resistance seems crucial to be able to adjust bacterial coverage of treatment to increase the chance of survival [6, 7] . Abdominal paracentesis is considered a mandatory approach in all patients with cirrhosis requiring hospital admission to diagnose infected ascites and also to assess treatment response based on ascitic neutrophil counts at baseline and after 2 days of antibiotic treatment [2, 3, 8] . However, in accordance with invasiveness of the technique, complications such as abdominal hematoma, hemoperitoneum or bowel perforation are rare but not impossible, while the procedure may also be challenging with difficulty of obtaining samples in some patients necessitating repetition of the procedure and thus increasing the risk of iatrogenic peritonitis [8] [9] [10] . The neutrophil-to-lymphocyte ratio (NLR) is an easily accessible biomarker of systemic inflammation that reflects the relationship between ongoing inflammation and immune regulatory pathway [2, 11] . Accordingly, NLR has been used to predict outcomes in cardiovascular diseases and various solid tumors including gastrointestinal, renal, gynecologic, and lung cancers, while the prognostic role has recently been indicated also in acute-on-chronic liver failure, nonalcoholic fatty liver disease, hepatocellular carcinoma, liver transplantation, and advanced cirrhosis [11] [12] [13] [14] . Advanced cirrhosis has been associated with a spontaneous increase in pro-inflammatory response due to imbalance between pro-inflammatory and anti-inflammatory signaling pathways. Although this suggests the potential role of NLR as a serological marker of bacterial infection in patients with cirrhosis, clinical rather than serological risk factors of bacterial infection have been more extensively investigated in cirrhosis patients, with little data available on serological markers such as NLR [15, 16] . The present study was therefore designed to investigate the utility of NLR as a serological marker in patients with cirrhotic ascites in the diagnosis of infected ascites and in monitoring treatment response.
MATERIALS AND METHODS

Study population
A total of 439 patients (mean (SD) age: 64.5 (± 12.7) years, 63.3% were males) with cirrhotic ascites hospitalized in a tertiary center within a 9-year period from 2008 to 2017 were included in this retrospective study. Patients with a concurrent secondary infection, malignancy, and serum ascites albumin gradient (SAAG) < 1.1 were excluded from the study population. The study was conducted in full accordance with local Good Clinical Practice guideline and current legislations, while the permission was obtained from Clinical Research and Ethics Committee of the University of Health Sciences Antalya Training and Research Hospital for the use of patient data for publication purposes (Date of Approval: 19/01/2017, Reference number/Protocol No: 2/13). Because of the retrospective design of the study no informed consent was obtained.
Study parameters
Data on patient demographics (age, gender), etiology of cirrhosis, type of ascites (sterile ascites, infected ascites), culture findings and treatment response and baseline (Day 0) levels for serum C-reactive protein (CRP; mg/L), erythrocyte sedimentation rate (ESR; mm/h) and NLR were recorded in each patient and compared between sterile vs. infected ascites groups. In patients with infected ascites, baseline (Day 0), Day 1, and Day 2 levels for NLR and CRP were analyzed with respect to treatment response groups (antibiotic resistance vs. sensitivity) and also for change from baseline in each group. Receiver operating characteristics (ROC) curve was plotted to determine performance of % change from baseline NLR in identification of antibiotic resistance in patients with infected ascites with calculation of area under curve (AUC) and cutoff value via ROC analysis.
Paracentesis and culture techniques
After local anesthesia with lidocaine administered using a 17-G needle, bedside diagnostic paracentesis was performed using a sterile method with a 23-G needle attached to a 20-cc syringe. Immediately after the paracentesis needle and attached syringe were withdrawn from the abdomen, the "skin" needle was removed and replaced with a sterile needle to minimize the risk of skin flora growing in the cultures. Next, the ascitic fluid was aspirated and collected into ethylene diamine tetraacetic acid tubes and analyzed within 3 hours of aspiration. Ascitic fluid was then centrifuged in the laboratory for 3 minutes and analyzed for total protein and total and differential leukocyte counts. A smear was prepared and stained with Giemsa. Peritoneal fluid collected from the patients was cultured using two methods. In the first method, 20 mL of peritoneal fluid was inoculated in aerobic blood culture bottles. These bottles were then placed in an automated BacT/Alert 3D (BioMerieux; Durham, NC, USA) culture system. Bottle incubation and subsequent testing were performed according to the manufacturer's protocol. In the second method, the remaining sample was cultured using conventional culture methods (i.e., inoculation using blood agar, MacConkey agar, and thioglycollate broth). The conventional agar and broth media were incubated at 35°C for up to 3 days before being discarded as negative. Bacterial iden-tification and antimicrobial susceptibility testing were performed using standard procedures.
Diagnosis of infected and sterile ascites and antibiotic resistance
The presence of ascitic fluid infection was determined on the basis of WBC/PMNL counts and culture positivity in ascitic fluid. Patients with WBC count ≥ 500/mm 3 and PMNL > 250/mm 3 in ascitic fluid were considered to have infected ascites, while those with WBC count < 500/mm 3 and PMNL count < 250/mm 3 in ascitic fluid and with a negative culture were considered to have sterile ascites. Antibiotic resistance was defined via paracentesis as the presence of < 25% decrease in pretreatment ascitic fluid WBC count after 2-day treatment [1, 9, 10] .
Blood tests for CRP and NLR
Serum CRP level was measured as high-sensitivity CRP by an immunoturbidimetric assay using the C-Reactive Protein High Sensitivity reagent (Beckman Coulter, Inc., Fullerton, CA, USA; limit of detection, 0.08 mg/ L). The NLR was calculated as the ratio of absolute neutrophil count and absolute lymphocyte count, given by the differential white blood cell count (WBC) measured by a Sysmex XE-2100 automated hematology analyzer (Sysmex Corporation).
Statistical analysis
Statistical analysis was made using IBM SPSS Statistics for Windows, Version 22.0 (IBM Corp., Armonk, NY). Fisher's exact test and Pearson's chi-square analysis performed for categorical variables. The normality assumptions of the analysis of the two-group measurement differences were controlled by the Shapiro-Wilk test. Mann-Whitney U test was used for analysis of nonnormally distributed numerical data while Student's t-test was used for normally distributed data. Spearman's correlation test was performed to test relationships in ordinal or quantitative variable with non-normal distribution. Wilcoxon Signed Ranks Test was applied to non-normally distributed paired variables. ROC curve was plotted to determine performance of % change from baseline NLR with calculation of AUC values and ideal cutoff value via ROC analysis. AUC values had the following interpretation: 0.9 -0.99 means an excellent test, 0.8 -0.89 means a good test, 0.7 -0.79 means a fair test or reasonable test, and 0.51 -0.69 means a poor test. Data are expressed as mean (standard deviation, SD) or median (min -max), as appropriate. p-values < 0.05 were considered statistically significant.
RESULTS
Baseline characteristics in the overall study population (n = 439) Cryptogenic cirrhosis was noted in 32.1% of patients, followed by HCV infection (21.4%), HBV infection (19.8%), and alcoholic hepatitis (18.0%) related etiologies underlying the cirrhosis. Infected ascites was identified in 227 (51.7%) patients and culture positivity in 82 (36.1%) patients with infected ascites. Escherichia coli (E. coli, 43.2%), coagulase-negative staphylococci (22.2%) and Enterococcus species (12.3%) were the three most commonly isolated pathogens. Of 227 patients with infected ascites, 49.8% were determined to be antibiotic sensitive and 50.2% to be antibiotic resistant (Table 1) .
Demographics and clinical characteristics and laboratory findings in sterile (n = 212) versus infected (n = 227) ascites groups When compared to sterile ascites, the infected ascites group was associated with higher percentage of females (41.9% vs. 31.1%, p = 0.020) and older age (66.1 (± 12.8) years vs. 62.9 (± 12.4) years, p = 0.009) as well as lesser prevalence of HBV infection (16.7% vs. 23.1%) and higher prevalence of cryptogenic (34.4% vs. 29.7%) and biliary (11.9% vs. 5.2%) cirrhosis (p = 0.049) ( Table 2) From baseline to Day 1 and to Day 2, NLR values showed a significant increase in antibiotic resistant patients (p < 0.001 for each), whereas a significant decrease from baseline was shown in antibiotic sensitive patients (p < 0.001 for each) ( Table 3) . Percentage of patients with an increase in NLR from baseline to Day 1 was significantly higher in case of antibiotic resistance when compared to antibiotic sensitivity (87.7% vs. 11.5%, p = 0.001) ( Table 3) . Baseline and Day 2 CRP levels were similar between antibiotic resistant and sensitive patients along with identification of no significant change from baseline to Day 2 CRP levels in each group (Table 3) .
ROC analysis
ROC analysis revealed less than 0.93% decrease from baseline (and/or any increase from baseline) NLR on Day 1 (AUC (95% CI): 0.852 (0.799 -0.895), p < 0.001) to be a potential marker of antibiotic resistance with a sensitivity of 87.72% and specificity of 88.50% ( Figure 1A) . Also, less than 8.95% decrease from baseline NLR on Day 2 (AUC (95% CI): 0.881 (0.832 -0.920), p < 0.001) was shown to be a potential marker of antibiot- 
Isolated pathogen
Escherichia coli
(43.2)
Coagulase-negative staphylococci
(22.2)
Staphylococcus aureus 3 (3.7)
Pseudomonas aeruginosa 4 (4.9)
Enterococcus spp.
(12.3)
Klebsiella spp.
(3.7)
Streptococcus spp.
(2.5)
Acinetobacter spp.
Salmonella spp.
(1.2)
Enterobacter spp. 
Table 3. Change in NLR and CRP levels in patients with infected ascites according to treatment response (n = 227).
Response to antibiotics p-value ic resistance with a sensitivity of 92.11% and specificity of 86.73% ( Figure 1B) . A significant positive correlation was noted between NLR and ascitic fluid WBC count on Day 2 (r = 0.363; p < 0.001) in patients with infected ascites. 
DISCUSSION
Our findings in a retrospective cohort of patients with cirrhotic ascites revealed infected ascites in 51.7% of patients and culture positivity and antibiotic resistance in 36.1% and 50.2% of patients with infected ascites, respectively. Although baseline NLR values were similar between sterile vs. infected ascites groups as well as between antibiotic resistant vs. sensitive patients with infected ascites, there was a significant change in Day 1 and Day 2 NLR levels with respect to treatment response with progressive increase and decrease from baseline in case of antibiotic resistance and antibiotic sensitivity, respectively. As a result, % change from baseline NLR on Day 1 was shown to be an early marker for differentiating between antibiotic resistance and antibiotic sensitivity with a sensitivity of 87.72% and specificity of 88.50%. Although paracentesis is the mainstay method in diagnosing infected ascites and monitoring treatment response to antibiotics in patients with cirrhotic ascites, it is an invasive method associated with certain drawbacks such as iatrogenic peritonitis particularly in conditions necessitating the repeat of procedure and the erroneous PMN count due to likelihood of hemorrhage and entry of leukocytes into the ascitic fluid during a traumatic paracentesis [1, 9, 10, 17] . In this regard, a vast array of potential analyses have been addressed in studies searching for alternative methods of SBP diagnosis including detection of leukocyte enzymes by strip tests, identification of bacterial DNA by molecular methods, ascetic fluid lactoferrin levels, inflammation or immune-derived mediators such as serum levels for procalcitonin, CRP, interleukin-6, neutrophil gelatinase-associated lipocalin (NGAL), lipopolysaccharide binding protein, and macrophage inflammatory protein-1 beta (MIP-1β) [2, [17] [18] [19] [20] . Moreover, a change in bacterial profile of SBP has been documented in recent studies with an increase in the incidence of gram-positive pathogens as well as a trend towards an increased frequency of bacteria resistant to multiple antibiotics [3, 21] . This has been attributed to the use of antibiotics that alter the intestinal flora enabling translocation of gram-positive bacteria, as well as increased resistance to antibiotics commonly used for the treatment of SBP such as quinolones [21] . Accordingly, coagulase-negative staphylococci and Enterococcus species were the two most commonly isolated pathogens following E. coli, while antibiotic resistance was evident in half of the patients with infected ascites in our cohort. This indicates the role of in-depth assessment of pathogen profiles in SBP to control the emer-gence and development of pathogenic bacteria-resistant strains, while also emphasizing the critical importance of earlier recognition of antibiotic resistance in patients with infected ascites to prevent fatal complications [3] . Our findings indicate changes from baseline in NLR differ significantly with respect to treatment response in patients with infected cirrhotic ascites with a progressive increase in NLR levels during treatment in case of antibiotic resistance. Percent change from baseline NLR on both Day 1 and Day 2 of antibiotic treatment were shown to be a potential marker of antibiotic resistance in our patients, defined otherwise via repeat paracentesis on Day 2 based on < 25% decrease in pretreatment ascitic fluid WBC count. Accordingly, our findings emphasize the role of NLR levels in the monitoring of treatment response and thus early recognition of treatment failure and prompt modification of antibiotic treatment in patients with SBP [1] . This seems also notable given that NLR refers to a potential rapid and non-invasive marker with high sensitivity and specificity that provides information at no cost, being calculated based on routinely performed complete blood count. Utility of change from baseline NLR in identification of antibiotic resistance on Day 1 of antibiotic treatment in patients with infected ascites is important given that failure of first-line empiric antibiotic therapy was associated with increased mortality [22] . Identification of antibiotic resistance as early as possible seems important in this regard, given the likelihood of prompt and appropriate treatment to maximize the patient's chance of survival and the fact that escalation of therapy after unsuccessful empiric therapy still carries an increased risk of mortality [4, 23] .
In fact, we have also showed that NLR value measured on Day 1 (cutoff value of > 5.52, AUC (95% CI): 0.659 (0.593 -0.720), p < 0.001) to directly determine antibiotic resistance, whereas consideration of absolute Day 1 NLR value showed much lower sensitivity (67.54%) and specificity (63.72%) as compared with consideration of % change from baseline NLR. Thus, our findings indicate considering % change from baseline rather than estimating a cutoff value for Day 1 NLR to be a more reliable approach in assessment of treatment failure in cirrhotic patients given the hypersplenism related changes in leukocyte counts in cirrhosis and the likelihood of already high pre-treatment NLR levels in case of advanced cirrhosis [11] . Cirrhotic patients with overt infection were reported to be old and female dominant and to have significantly higher baseline NLR and CRP compared to those without infection, while NLR > 4.85, CRP > 59.4 mg/L, and lymphocytes ≤ 900/mm 3 were also documented to be associated with increased risk of infection in cirrhotic patients [11, 15] . Likewise, infected vs. sterile ascites groups in our cohort differed significantly with identification of older age, higher percentage of females, more common cryptogenic etiology, and higher baseline CRP levels in the infected ascites group, while the two groups had similarly high baseline NLR levels.
Increased NLR has been suggested to be a more powerful predictor of infection than simple WBC counts and to be a potential poor prognostic marker in cirrhotic patients, since it reflects the early hyper-dynamic phase of infection characterized by a pro-inflammatory state with suppression of neutrophil apoptosis and increased lymphocyte apoptosis [3, 11, 24] . As a result, increased NLR has been associated with neutrophil mediated suppression of T cell activation through the production of arginase, nitric oxide, and reactive oxygen species leading to depletion of lymphocyte-mediated immune response [3, 11, 25] . Notably, subclinical low dose endotoxemia due to circulating bacterial DNA has been associated with a systemic inflammatory response that induces a rise in blood neutrophil count and fall in total lymphocyte count even in stable cirrhotic patients, while the imbalance of immune cells is considered likely to put cirrhotic patients at increased risk of bacterial infections [3, 16, 26] . Identification of similarly high baseline NLR levels in patients with infected and sterile cirrhotic ascites in our cohort seems notable in this regard, emphasizing the overall imbalance between pro-inflammatory and antiinflammatory signaling pathways in immune cells in cirrhotic patients and the likelihood of continuing risk at least for other bacterial infections in our patients with sterile cirrhotic ascites [14] . Increased NLR was also suggested to be associated with malnutrition which has been associated with higher risk of refractory ascites, more severe disease, and shortterm survival in cirrhotic patients. Hence, given that cirrhosis progressed to ascites stage in our patients, the potential impact of nutritional status on identification of high baseline NLR levels, regardless of type of ascites, seems also likely [3, 27] . Moreover, the localized nature of early stage infection in cirrhotic ascites along with typical delayed immune response in the cirrhotic patients may have also contributed to the presence of similarly high baseline NLR levels in infected and sterile ascites groups. Hence, the difference between resistant and sensitive groups on Day 1 NLR might have appeared depending on the treatment response with or without progression to systemic infection and activation of related immune mechanisms. Nonetheless, it is beyond the scope of the present study to reveal the potential mechanisms underlying the association between NLR and ascites infection in cirrhosis, which renders the proposed assumptions questionable and potentially speculative. Given the similar Day 0 levels of NLR in antibiotic resistant and sensitive groups of patients with infected ascites, the identification of a progressive increase in NLR levels in case of antibiotic resistance and progressive decrease in NLR levels in case of antibiotic sensitivity during first 2 days of treatment emphasize the utility of NLR as a reliable marker of treatment response in infected ascites. Alongside well-known in vitro effects of a wide range of antibiotics on granulocyte chemotaxis and lymphocyte function, this may also indicate the likelihood of treatment associated alterations in peripheral blood neutrophil counts that may reflect the selective increase in bacteria populations not covered by the prescribed antibiotic regimen. Notably, in mice treated with antibiotic effective against gram-positive bacteria, selective increase of gram negative populations of bacteria in colon and stool was shown to be accompanied by the increased percentage of neutrophils in peripheral blood of antibiotic treated mice as compared with the control mice [28] . Although significantly higher baseline CRP levels in infected ascites than in sterile ascites group in our cohort support the consideration of CRP as a marker of cirrhosis associated bacterial infections, our findings indicate no significant role of CRP levels in monitoring treatment response in cirrhotic patients with infected ascites given the lack of a significant change from baseline levels during treatment in both sterile and infected ascites groups. Notably, in a retrospective analysis of cirrhotic patients treated for SBP, serum high sensitivity CRP (hs-CRP) level was reported to be an independent predictor of lower antibiotic response rate (OR = 0.916, p < 0.001). However, based on negative correlation of hs-CRP with the CP score and Model for End-Stage Liver Disease score, authors suggested that the prognostic function of hs-CRP was not a surrogate for hepatic dysfunction [29] . Certain limitations to this study should be considered. First, due to the retrospective single center design of the present study, establishing the temporality between cause and effect as well as generalizing our findings to overall cirrhotic population seems difficult. Second, elucidation of the mechanisms underlying the association of NLR with infection in cirrhotic ascites was not within the scope of our study which otherwise would extend the knowledge achieved in the current study. Nevertheless, despite these certain limitations, given the restricted amount of data available on the potential role of early markers of treatment response in patients with infected cirrhotic ascites, our findings represent a valuable contribution to the literature.
CONCLUSION
Our findings indicate association of treatment response with progressive changes in NLR from baseline in patients with infected ascites, being towards higher and lower NLR levels in case of antibiotic resistance and antibiotic sensitivity, respectively. Percent change from baseline NLR on Day 1 was shown to be a potential early marker of antibiotic resistance in patients with infected cirrhotic ascites, defined otherwise via repeat paracentesis on Day 2 of antibiotic treatment. Accordingly, our findings emphasize the role of determining change from baseline in NLR levels in earlier recognition of treatment failure and thus prompt modification of antibiotic treatment in patients with infected ascites. Future larger scale prospective studies addressing the potential mechanisms underlying the association of NLR with infections and treatment response in cirrhotic patients are needed to determine utility and clinical relevance of NLR as a readily available tool in the routine management of patients with ascites.
